Brookstone Hires Head of Life Sciences Investments

Nov 11 2005 | 8:22pm ET

Scott Moonly has been appointed v.p. of life science investments for Brookstone Capital, which specializes in alternative investment opportunities.

Moonly, who joins the firm from L.E.K. Consulting, will be responsible for identifying life science investment opportunities and performing due diligence on both private and public companies. He holds a Ph.D. in biomedical engineering.

In addition to working at L.E.K. Consulting, Moonly has served as an investment analyst with the Merrill Lynch Healthcare Group where he provided financial and strategic analysis for biotechnology and medical device companies. Brookstone has offices in Costa Mesa, Calif. and Las Vegas.


In Depth

Humble in Hofstra...One Debate an Election Can Make

Sep 26 2016 | 10:20am ET

Tonight's U.S. Presidential debate, infamously coined the “Humbling in Hofstra...

Lifestyle

Quattrex Sports AG Debuts Soccer-Focused UCITS Fund

Sep 9 2016 | 9:54pm ET

Innovative alternative investment company Quattrex Sports has unveiled a new UCITS...

Guest Contributor

Malik: The Ever-Changing Middle Market and The Entering Class of 2016

Sep 2 2016 | 5:01pm ET

Deal sourcing and origination is only going to get more competitive given current...